Analgesic effects of piritramide in acute postoperative pain - comparison of intramuscular administration with patient-controlled intravenous analgesia and impact of OPRM1 and ABCB1 polymorphisms
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
33252118
DOI
10.5507/bp.2020.053
Knihovny.cz E-zdroje
- Klíčová slova
- adverse effects, analgesia, gene polymorphism, intramuscular administration, opioid, patient-controlled intravenous analgesia, piritramide, postoperative pain,
- MeSH
- lidé MeSH
- opioidní analgetika MeSH
- P-glykoproteiny genetika MeSH
- pacientem kontrolovaná analgezie * MeSH
- pirinitramid * terapeutické užití MeSH
- polymorfismus genetický MeSH
- pooperační bolest farmakoterapie MeSH
- receptory opiátové mu terapeutické užití MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ABCB1 protein, human MeSH Prohlížeč
- opioidní analgetika MeSH
- OPRM1 protein, human MeSH Prohlížeč
- P-glykoproteiny MeSH
- pirinitramid * MeSH
- receptory opiátové mu MeSH
AIMS: The aim of this study was to compare the efficacy, consumption and safety after piritramide administered either intramuscularly (IM) on demand or via patient-controlled intravenous analgesia (PCA) and to examine the impact of OPRM1 and ABCB1 gene polymorphisms on the drug efficacy/safety in both regimens. METHODS: One hundred and four patients scheduled for elective inguinal hernioplasty received piritramide with PCA or IM for postoperative pain management. We evaluated piritramide consumption, pain intensity using visual analogue scale (VAS) and adverse effects. RESULTS: Median (IQR) piritramide consumption was 18.5 (13.5-31.2) and 15.0 (15.0-15.0) mg in the PCA and IM groups, respectively (P=0.0092). The respective values of area under the VAS2-16-time curve were 40 and 280 mm.h (P=0.0027). Opioid-induced adverse effects were more frequent in the PCA than in the IM group. Variant OPRM1 allele was associated with decreased pain relief, increased opioid consumption and increased incidence of adverse effects, while ABCB1 polymorphisms showed no impact on the observed parameters. CONCLUSIONS: We observed higher piritramide consumption, better pain relief and slightly worse safety profile in the PCA group compared with IM administration. Variant OPRM1 118G allele carriers required higher opioid dosing and suffered from more adverse effects, however, the differences between genotypes have been less pronounced in the PCA patients likely due to improved pain management via PCA.
Zobrazit více v PubMed
Bethell J, Neuman MD, Bateman BT, Hill AD, Ladha KS, Wijeysundera DN, Wunsch H. Age and postoperative opioid prescriptions: a population-based cohort study of opioid-naive adults. Pharmacoepidemiol Drug Saf 2020;29(4):504-9. DOI
Pestano CR, Lindley P, Ding L, Danesi H, Jones JB. Meta-Analysis of the Ease of Care From the Nurses' Perspective Comparing Fentanyl Iontophoretic Transdermal System (ITS) Vs Morphine Intravenous Patient-Controlled Analgesia (IV PCA) in Postoperative Pain Management. J Perianesth Nurs 2017;32(4):329-40. PubMed DOI
Gulcin Ural S, Yener O, Sahin H, Simsek T, Aydinli B, Ozgok A. The comparison of analgesic effects of various administration methods of diclofenac sodium, transdermal, oral and intramuscular, in early postoperative period in laparoscopic cholecystectomy operations. Pak J Med Sci 2014;30(1):96-100.
Katz P, Takyar S, Palmer P, Liedgens H. Sublingual, transdermal and intravenous patient-controlled analgesia for acute post-operative pain: systematic literature review and mixed treatment comparison. Curr Med Res Opin 2017;33(5):899-910. DOI
Everett B, Salamonson Y. Differences in postoperative opioid consumption in patients prescribed patient-controlled analgesia versus intramuscular injection. Pain Manag Nurs 2005;6(4):137-44. PubMed DOI
Hinrichs M, Weyland A, Bantel C. Piritramide: A critical review. Schmerz 2017;31(4):345-52. DOI
Bakhouche H, Noskova P, Svetlik S, Bartosova O, Ulrichova J, Kubatova J, Marusicova P, Parizek A, Blaha J, Slanar O. Maternal and neonatal effects of remifentanil in women undergoing cesarean section in relation to ABCB1 and OPRM1 polymorphisms. Physiol Res 2015;64(Suppl 4):S529-38. DOI
Hronova K, Pokorna P, Posch L, Slanar O. Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome. Physiol Res 2016;65(Suppl 4):S463-S72. DOI
Khalil H, Sereika SM, Dai F, Alexander S, Conley Y, Gruen G, Meng L, Siska P, Tarkin I, Henker R. OPRM1 and COMT Gene-Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma. Biol Res Nurs 2017;19(2):170-9. PubMed DOI
Bartosova O, Polanecky O, Perlik F, Adamek S, Slanar O. OPRM1 and ABCB1 polymorphisms and their effect on postoperative pain relief with piritramide. Physiol Rese 2015;64(Suppl 4):S521-7. DOI
Kim KM, Kim HS, Lim SH, Cheong SH, Choi EJ, Kang H, Choi HR, Jeon JW, Yon JH, Oh M, Shin JG. Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients. Int J Clin Pharmacol Ther 2013;51(5):383-92. DOI
Zhao Z, Lv B, Zhao X, Zhang Y. Effects of OPRM1 and ABCB1 gene polymorphisms on the analgesic effect and dose of sufentanil after thoracoscopic-assisted radical resection of lung cancer. Biosci Rep 2019;39(1):BSR20181211. DOI
Pechandova K, Buzkova H, Slanar O, Perlik F. Polymorphisms of the MDR1 gene in the Czech population. Folia Biol 2006;52(6):184-9.
McNicol ED, Ferguson MC, Hudcova J. Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain. Cochrane Database Syst Rev 2015:2015(6):CD003348. DOI
Hwang IC, Park JY, Myung SK, Ahn HY, Fukuda K, Liao Q. OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis. Anesthesiology 2014;121(4):825-34. PubMed DOI
Bartosova O, Polanecky O, Sachl R, Stenglova Netikova I, Perlik F, Adamek S, Lischke R, Slanar O. Epidural analgesia with sufentanil in relation to OPRM1 and ABCB1 polymorphisms. Physiol Res 2019;68(Suppl 1):S59-S64. DOI
Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Clin Pharmacokinet 2015;54(7):709-35. DOI